LBRX LB Pharmaceuticals Inc.
Health Care, filed as LB PHARMACEUTICALS INC (COM SHS), Equity As of 2026 Q2 among managers we track Quote on Google Finance, opens in a new tab
- 1 exit
In 2026 Q2 James Silverman sold out of LB Pharmaceuticals.
Who owns LBRX
Sorted by value, long equity only, as of 2026 Q2. Exits show their last held size.
| History | |||||
|---|---|---|---|---|---|
| James Silverman, Opaleye Management exited 2026 Q2 Last 2026 Q1 | Exit −0.05% | 14,506 | $358K | History |
SEC filings
Recent issuer filings from EDGAR, 25 shown.
| Filed | Form | Detail | Links |
|---|---|---|---|
| SCHEDULE 13G/A | — | Filing Doc | |
| 424B3 | Filing Doc | ||
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 8-K | 5.02,7.01,9.01 | Filing Doc | |
| 424B3 | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc | ||
| 424B3 | Filing Doc | ||
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 1.01,3.02,7.01,9.01 | Filing Doc | |
| 424B3 | Filing Doc | ||
| 8-K | 8.01,9.01 | Filing Doc | |
| 424B3 | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| 8-K | 5.02,9.01 | Filing Doc | |
| 424B3 | Filing Doc | ||
| 8-K | 5.07 | Filing Doc | |
| 424B3 | Filing Doc | ||
| SCHEDULE 13G | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| SCHEDULE 13G/A | — | Filing Doc | |
| 8-K | 2.02,9.01 | Filing Doc | |
| 10-Q | Filing Doc |
No filings match this filter.
Financials
US-GAAP annual figures by fiscal year, as tagged in Form 10-K. Each value links to its SEC filing.
Income statement
| Metric | FY2025 |
|---|---|
| Net income | -$25.2M |
Balance sheet
Ownership over time
13Fs that reported it each quarter. Click a bar for that quarter’s holders.